Aprea Therapeutics
APRE
APRE
34 hedge funds and large institutions have $1.52M invested in Aprea Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 9 closing their positions.
Holders
34
Holders Change
-6
Holders Change %
-15%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
11
Reduced
11
Closed
9
Calls
$477K
Puts
$10K
Net Calls
+$467K
Net Calls Change
-$616K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$264K |
| 2 |
2
Jane Street
New York
|
$54K |
| 3 |
3
Two Sigma Investments
New York
|
$45K |
| 4 |
4
D.E. Shaw & Co
New York
|
$37K |
| 5 |
5
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
$15K |
